Afficher la couverture 'p53 Acts as a Safeguard of Translational Control by Regulating Fibrillarin and rRNA Methylation in Cancer | Marcel, Virginie' en grand format
/5

0 avis

p53 Acts as a Safeguard of Translational Control by Regulating Fibrillarin and rRNA Methylation in Cancer

Archive ouverte

Marcel, Virginie | Ghayad, Sandra E. | BELIN, Stephane | Therizols, Gabriel | Morel, Anne-Pierre | Solano-Gonzàlez, Eduardo | Vendrell, Julie A. | Hacot, Sabine | Mertani, Hichem C. | Albaret, Marie Alexandra | Bourdon, Jean-Christophe | Jordan, Lee | Thompson, Alastair | Tafer, Yasmine | Cong, Rong | Bouvet, Philippe | Saurin, Jean-Christophe | Catez, Frédéric | Prats, Anne-Catherine | Puisieux, Alain | Diaz, Jean-Jacques

Edité par CCSD ; Elsevier -

International audience. Ribosomes are specialized entities that participate in regulation of gene expression through their rRNAs carrying ribozyme activity. Ribosome biogenesis is overactivated in p53-inactivated cancer cells, although involvement of p53 on ribosome quality is unknown. Here, we show that p53 represses expression of the rRNA methyl-transferase fibrillarin (FBL) by binding directly to FBL. High levels of FBL are accompanied by modifications of the rRNA methylation pattern, impairment of translational fidelity, and an increase of internal ribosome entry site (IRES)-dependent translation initiation of key cancer genes. FBL overexpression contributes to tumorigenesis and is associated with poor survival in patients with breast cancer. Thus, p53 acts as a safeguard of protein synthesis by regulating FBL and the subsequent quality and intrinsic activity of ribosomes.

Suggestions

Du même auteur

Ribosomal RNA 2′O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer

Archive ouverte | Marcel, Virginie | CCSD

International audience. Recent epitranscriptomics studies unravelled that ribosomal RNA (rRNA) 2′O-methylation is an additional layer of gene expression regulation highlighting the ribosome as a novel actor of trans...

Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer

Archive ouverte | Nguyen van Long, Flora | CCSD

International audience. Background: A current critical need remains in the identification of prognostic and predictive markers in early breast cancer. It appears that a distinctive trait of cancer cells is their add...

Alteration of ribosome function upon 5-fluorouracil treatment favors cancer cell drug-tolerance

Archive ouverte | Therizols, Gabriel | CCSD

JOBIM 2023 - Journées Ouvertes en Biologie, Informatique et Mathématiques, NIce 2023. International audience. Mechanisms of drug-tolerance remain poorly understood and have been linked to genomic but also to non-gen...

Chargement des enrichissements...